Hospital
Mercer County Joint Township Community Hospital
Mercer County Joint Township Community Hospital was paid $6.33M by Medicaid between Jan 2018 and Dec 2024, across 157 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 13% of everything it billed.
33Billing provider infoMERCER COUNTY JOINT TOWNSHIP COMMUNITY HOSPITAL
COLDWATER, OH 45828
COLDWATER, OH 45828
33aNPI1497784144assigned 07/02/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.33M
24GClaims181,689
24DCodes billed157
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Ohio
Rank by total paid#84 of 101
Median peer was paid$22.32M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,614 | $423K | |
| 2019 | 12,248 | $381K | |
| 2020 | 11,035 | $483K | |
| 2021 | 14,523 | $696K | |
| 2022 | 16,078 | $682K | |
| 2023 | 69,038 | $2.25M | |
| 2024incomplete | 46,153 | $1.42M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 13,599 | 10,396 | $832K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 10% | 10,973 | 8,477 | $638K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 9.5% | 8,332 | 6,383 | $599K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.8% | 5,704 | 4,391 | $497K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 7.4% | 6,042 | 4,862 | $471K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 6.1% | 5,445 | 1,309 | $386K |
| 96361 | Intravenous infusion, hydration; each additional hour | 5.9% | 1,379 | 878 | $374K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 4.6% | 3,987 | 1,278 | $294K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.2% | 3,216 | 2,830 | $268K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.6% | 3,848 | 3,372 | $167K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.4% | 886 | 823 | $152K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.2% | 590 | 442 | $137K |
145 more codes
| 70450 | Computed tomography, head or brain; without contrast material | 1.7% | 563 | $111K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.5% | 1,481 | $98K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.5% | 1,369 | $95K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.3% | 1,015 | $81K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.1% | 3,148 | $68K |
| 80053 | Comprehensive metabolic panel | <1% | 2,566 | $62K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,859 | $60K |
| G0378 | Hospital observation service, per hour | <1% | 929 | $60K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 241 | $56K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 9,164 | $54K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 518 | $51K |
| 97803 | <1% | 593 | $49K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 773 | $42K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 292 | $42K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,451 | $34K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,158 | $34K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,861 | $31K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 262 | $25K |
| 84439 | <1% | 993 | $23K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,144 | $22K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 565 | $21K |
| 87632 | <1% | 184 | $21K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 16,161 | $21K |
| 97161 | <1% | 562 | $20K | |
| 80061 | Lipid panel | <1% | 1,418 | $20K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 248 | $20K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 125 | $16K |
| 87070 | <1% | 939 | $12K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 916 | $12K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,005 | $11K |
| J3490 | Unclassified drugs | <1% | 1,088 | $11K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 2,515 | $11K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 561 | $10K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,955 | $10K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 712 | $10K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 420 | $10K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,106 | $10K |
| 87081 | <1% | 505 | $9K | |
| 80076 | <1% | 3,712 | $9K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 83 | $8K |
| 86140 | <1% | 637 | $8K | |
| 74018 | <1% | 150 | $7K | |
| 87088 | <1% | 1,108 | $7K | |
| 82728 | <1% | 353 | $6K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,075 | $6K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 113 | $5K |
| 82607 | <1% | 237 | $5K | |
| 87077 | <1% | 763 | $5K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 257 | $5K |
| 81001 | <1% | 3,760 | $5K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 16 | $4K |
| 82570 | <1% | 362 | $3K | |
| 87205 | <1% | 737 | $3K | |
| 87186 | <1% | 745 | $3K | |
| 83735 | <1% | 1,385 | $3K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 46 | $3K |
| 83540 | <1% | 299 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 244 | $3K |
| A0425 | Ground mileage, per statute mile | <1% | 50 | $3K |
| 84484 | <1% | 2,169 | $3K | |
| 86850 | <1% | 102 | $3K | |
| 83550 | <1% | 282 | $3K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 188 | $3K |
| 86592 | <1% | 130 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 229 | $2K |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 106 | $2K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 39 | $2K |
| 85651 | <1% | 448 | $2K | |
| 0012A | <1% | 67 | $2K | |
| 82947 | <1% | 1,143 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,032 | $2K |
| 83690 | <1% | 1,263 | $2K | |
| Q3014 | Telehealth originating site facility fee | <1% | 90 | $2K |
| 81003 | <1% | 450 | $2K | |
| 83880 | <1% | 383 | $2K | |
| 0011A | <1% | 75 | $2K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 348 | $2K |
| 85610 | <1% | 560 | $1K | |
| 86900 | <1% | 128 | $1K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,225 | $1K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 321 | $1K |
| 87340 | <1% | 76 | $1K | |
| 82043 | <1% | 174 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,143 | $1K |
| 73630 | <1% | 46 | $940.29 | |
| 85027 | <1% | 360 | $887.20 | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 166 | $881.98 |
| 87210 | <1% | 76 | $808.24 | |
| 86901 | <1% | 128 | $748.58 | |
| 86803 | <1% | 34 | $620.23 | |
| 81025 | <1% | 837 | $599.50 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 51 | $577.18 |
| 82746 | <1% | 49 | $538.43 | |
| 85007 | <1% | 152 | $506.77 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,296 | $479.58 |
| 84403 | <1% | 17 | $476.61 | |
| 86038 | <1% | 18 | $430.16 | |
| 84702 | <1% | 19 | $415.35 | |
| 84145 | <1% | 43 | $408.69 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 945 | $387.00 |
| 82077 | <1% | 512 | $384.97 | |
| 99223 | Prolong inpt eval add15 m | <1% | 13 | $346.29 |
| 73130 | <1% | 22 | $334.95 | |
| 73610 | <1% | 21 | $333.87 | |
| 83605 | <1% | 299 | $284.15 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 779 | $248.76 |
| 11721 | <1% | 13 | $247.79 | |
| 97116 | <1% | 27 | $244.73 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,179 | $225.82 |
| 73030 | <1% | 19 | $223.63 | |
| 82950 | <1% | 19 | $206.19 | |
| 86308 | <1% | 21 | $203.90 | |
| 73560 | <1% | 34 | $171.57 | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 18 | $169.21 |
| 85379 | <1% | 111 | $154.48 | |
| 87040 | <1% | 340 | $149.88 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 549 | $126.86 |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 19 | $114.13 |
| 85730 | <1% | 128 | $94.08 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,108 | $84.04 |
| 84100 | <1% | 25 | $75.36 | |
| 80179 | <1% | 150 | $74.59 | |
| J2704 | Injection, propofol, 10 mg | <1% | 951 | $53.90 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 510 | $39.56 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,378 | $30.14 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 785 | $30.04 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 419 | $29.21 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 351 | $22.17 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 143 | $13.46 |
| 80143 | <1% | 145 | $11.38 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 57 | $6.09 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 102 | $3.93 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 39 | $3.89 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 48 | $0.72 |
| 91301 | <1% | 93 | $0.69 | |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | <1% | 20 | $0.10 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 93 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 23 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 26 | $0.00 |
| 29515 | 0% | 12 | $0.00 | |
| 96376 | 0% | 122 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 13 | $0.00 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 19 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 12 | $0.00 |
| 76830 | Ultrasound, transvaginal | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDINGLEDINE, JON (CFO/COO)
| Provider | Location | Paid |
|---|---|---|
| Mercer County Joint Township Community Hospital | Celina, OH | $61K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.